Disclosures for "IFN-γ–Inducible Chemokines CXCL9 and CXCL10 in Relation to Stroke Risk: The Northern Manhattan Study"
-
Dr. Nafeli Shahrestani has nothing to disclose.
-
Dr. Agudelo has nothing to disclose.
-
Dr. Veledar has nothing to disclose.
-
Ms. Gardener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intersocietal Accreditation Commission. Ms. Gardener has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ellipse Analytics. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Baum Hedlund. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with A Green Slate Consulting.
-
Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
-
Carolina Gutierrez has nothing to disclose.
-
The institution of Dr. Tom has received research support from National Institutes of Health . Dr. Tom has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Alzheimer's Association .
-
The institution of Dr. Rundek has received research support from NIH.